1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. United States >
  5. Connecticut >
  6. Olympus Partners >
  7. M&A

Olympus Partners Mergers & Acquisitions

Olympus Partners M&A Summary

In the last 3 years, Olympus Partners has acquired 7 companies.

In the last 3 years, Olympus Partners has exited 6 companies. The Firm’s most common exit type is trade sale (48%). Olympus Partners’ largest (disclosed) exit occurred in 2024 when it sold Soliant Health for $2.5B.

Sign-up to view Olympus Partners’ full profile and discover more mega-sized private equity firm investors just like it.

M&A Summary

  • M&A Total Activity105
    • M&A Buy Activity55
    • M&A Sell Activity50
  • M&A Buy/Sell Connections43

Olympus Partners

Olympus Partners

Metro Center, One Station Place,
Stamford, Connecticut 06902
United States
(203) 353-5900
www.olympuspartners.com

All (105) Buy (55) Sell (50)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-02-24 PAI Pharma · Life Science
Greenville, South Carolina · www.paipharma.com

PAI Pharma manufactures and markets generic oral liquid pharmaceuticals in the USA. The company produces oral suspensions, solutions, elixirs, syrups, and liquids. Core product categories include analgesic pain relief, cough/cold and allergies, digestive and metabolic health, neurological disorders, and mental health, among many others. PAI Pharma was founded in 1968 and is based in Greenville, South Carolina.

Advisors: Bourne Partners Investment Banking , RBC Capital Markets 		- Secondary Buyout

Monroe Capital PE

Olympus Partners PE

Bourne Partners Strategic Capital PE

Enhanced Healthcare Partners PE

Leavitt Equity Partners PE


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal